Related Experiment Videos

Health-care utilization and respiratory morbidities in preterm infants with pulmonary hypertension

B D Stuart1, P Sekar, J D Coulson

  • 1Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.

Journal of Perinatology : Official Journal of the California Perinatal Association
|January 19, 2013
PubMed

Insights

Pulmonary hypertension (PH) in preterm infants with bronchopulmonary dysplasia (BPD) significantly increases initial hospitalization duration and the need for home respiratory support. This highlights the importance of addressing PH in BPD management.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Critical Care

Background:

  • Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting preterm infants.
  • Pulmonary hypertension (PH) is a serious complication in infants with BPD.
  • Understanding the impact of PH on BPD outcomes is crucial for clinical management.

Purpose of the Study:

  • To evaluate healthcare utilization in preterm infants diagnosed with BPD and PH.
  • To determine the risk of respiratory morbidities in preterm infants with BPD and PH.

Main Methods:

  • Retrospective cohort study of 109 infants attending a BPD clinic.
  • Infants stratified based on the presence or absence of PH at/after 2 months of age.
  • Statistical analyses included t-tests, chi-squared tests, and regression modeling.

Main Results:

  • Infants with BPD and PH after 2 months experienced 2.2 months longer hospitalization (P=0.02).
  • These infants were 4.5 times more likely to require home oxygen or mechanical ventilation (P=0.03).
  • No significant difference in post-discharge respiratory morbidity risk was observed based on PH status.

Conclusions:

  • PH in preterm infants with BPD is linked to prolonged initial hospital stays and increased home respiratory support needs.
  • Findings underscore the need for comprehensive family counseling regarding the medical, psychosocial, and economic burdens associated with BPD and PH.
  • Early identification and management of PH are critical for improving outcomes in preterm infants with BPD.
Abstract

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Respiratory System Abnormal Finding I: Inspection and Percussion01:30

Respiratory System Abnormal Finding I: Inspection and Percussion

Respiratory system abnormalities are a significant concern in healthcare due to their potential to indicate underlying severe conditions like Chronic Obstructive Pulmonary Disease (COPD), asthma, and pneumonia. These abnormalities can often be detected through physical examination methods like inspection and percussion.
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...